CRISPR/Cas9 technology generated a G to A change resulting in an arginine to glutamine substitution at amino acid 400 (p.R400Q) in exon 13. This is a rare mutation seen in individuals with cardiomyopathy. (J:342938)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count